Tianjin Development (00882.HK) subsidiary invests 30 million yuan to subscribe for Industrial Bank wealth management products.

Financial APP news, Tianjin Development (00882.HK) announced that on November 19, 2025, Lisheng Pharmaceutical (an indirectly non-wholly-owned subsidiary of the company) signed the eleventh ICBC wealth management agreement with ICBC Wealth Management and Industrial Bank, subscribing to another fixed income investment product with a principal amount of RMB 30 million (equivalent to approximately HKD 32.82 million).